TP53 and central nervous system cancer: Somatic alterations analysis revealed that gliomas with high PDI signature and risk score were associated with genomic aberrations of driver oncogenes (TTN, MUC16, PIK3CA), but had less mutations of IDH1, TP53, and ATRX.